H.C. Wainwright Maintains Buy on Urovant Sciences, Raises Price Target to $33

H.C. Wainwright maintains Urovant Sciences (NASDAQ:UROV) with a Buy and raises the price target from $28 to $33.

Benzinga · 12/31/2019 12:17

H.C. Wainwright maintains Urovant Sciences (NASDAQ:UROV) with a Buy and raises the price target from $28 to $33.